Technical Analysis for NNVC - NanoViricides, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
B | 1.94 | -4.43% | -0.09 |
Earnings due: May 13
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing High | Bullish | -4.43% | |
New Uptrend | Bullish | -4.43% | |
Pocket Pivot | Bullish Swing Setup | -4.43% | |
Volume Surge | Other | -4.43% | |
Wide Range Bar | Range Expansion | -4.43% | |
New 52 Week High | Strength | -4.43% | |
Stochastic Reached Overbought | Strength | -4.43% | |
Upper Bollinger Band Walk | Strength | -4.43% | |
Wide Bands | Range Expansion | -4.43% | |
Above Upper BB | Strength | -4.43% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 1 hour ago |
Down 1 ATR | about 1 hour ago |
Fell Below Upper Bollinger Band | about 2 hours ago |
2x Volume Pace | about 2 hours ago |
1.5x Volume Pace | about 2 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 05/13/2024
NanoViricides, Inc. Description
NanoViricides, Inc. a nano-biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of viral infections. The company is developing anti-influenza drug candidates at advanced pre-clinical stage, which include two FluCide drugs comprising NV-INF-2, an oral anti-influenza drug and NV-INF-1, a injectable anti-influenza drug for novel strain of H7N9, Bird Flu H5N1, and other Highly Pathogenic Influenzas; HIVCide, an anti-human immunodeficiency virus (HIV) drug candidate that could enable a functional cure for HIV/AIDS; HerpeCide, a skin cream or gel formulation for the treatment of oral and genital herpes lesions; Nanoviricide anti-viral eye drops against external eye viral infections; and DengueCide, a treatment against Dengue viruses. It is also developing RabiCide, an anti-rabies nanoviricide; and Nanoviricide for the treatment of various strains of Ebola and Marburg filoviruses. The company has licenses to develop drugs for the treatment of human viral diseases, such as H5N1 (avian flu), human influenza, human immunodeficiency virus (HIV/AIDS), hepatitis B virus, hepatitis C virus, herpes simplex virus, and rabies; and dengue viruses, Japanese encephalitis virus, West Nile virus, viruses causing viral conjunctivitis and ocular herpes, and Ebola/Marburg viruses, as well as viral diseases of the eye comprising epidemic kerato-conjunctivitis and herpes keratitis. NanoViricides, Inc. was founded in 2005 and is based in West Haven, Connecticut.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Medicine Infectious Diseases Eye Infection Influenza Coronavirus Hepatitis B Viruses HIV Hepatitis C Immunodeficiency Hepatitis C Virus Virus Hepatitis B Virus Viral Disease Antiviral Drug HIV/Aids Herpes Rabies Ebola Herpes Simplex Dengue Epidemiology Herpes Simplex Virus Viral Infections Genital Herpes Viral Conjunctivitis Viral Infection
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.07 |
52 Week Low | 1.0 |
Average Volume | 73,903 |
200-Day Moving Average | 1.23 |
50-Day Moving Average | 1.22 |
20-Day Moving Average | 1.24 |
10-Day Moving Average | 1.31 |
Average True Range | 0.15 |
RSI (14) | 80.92 |
ADX | 26.43 |
+DI | 47.78 |
-DI | 8.50 |
Chandelier Exit (Long, 3 ATRs) | 1.61 |
Chandelier Exit (Short, 3 ATRs) | 1.49 |
Upper Bollinger Bands | 1.69 |
Lower Bollinger Band | 0.79 |
Percent B (%b) | 1.39 |
BandWidth | 71.92 |
MACD Line | 0.10 |
MACD Signal Line | 0.02 |
MACD Histogram | 0.0806 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.60 | ||||
Resistance 3 (R3) | 2.55 | 2.31 | 2.51 | ||
Resistance 2 (R2) | 2.31 | 2.16 | 2.34 | 2.47 | |
Resistance 1 (R1) | 2.17 | 2.08 | 2.24 | 2.22 | 2.44 |
Pivot Point | 1.93 | 1.93 | 1.97 | 1.96 | 1.93 |
Support 1 (S1) | 1.79 | 1.78 | 1.86 | 1.84 | 1.62 |
Support 2 (S2) | 1.55 | 1.70 | 1.58 | 1.59 | |
Support 3 (S3) | 1.41 | 1.55 | 1.56 | ||
Support 4 (S4) | 1.46 |